XIth Eurasian Hematology-Oncology Congress - EHOC 2020


 

Curative Options for Hemoglobinopathies: Is MSD the SoC in Thalassemia and Sickle Cell Disease Compared to MUD and Haploidentical HSCT?

43 views
January 18, 2021
Comments 0
Login to view comments. Click here to Login